Sulfated Polysaccharide Analysis via Segmentation and Multi-Parameter Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing and monitoring low molecular weight heparin (LMWH) products are inadequate due to structural heterogeneity, leading to unpredictable pharmacokinetics, side effects, and limited availability of reliable monitoring techniques, which restricts their use to specific patient populations and hampers batch-to-batch consistency and therapeutic efficacy.
Innovation Solution
Development of methods to analyze and monitor heterogeneous populations of sulfated polysaccharides, including LMWH, by determining structural signatures and activity profiles using techniques such as MALDI-MS, ESI-MS, and HPLC, allowing for the standardization of polysaccharide preparations and improved bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If structural heterogeneity of sulfated polysaccharides is analyzed using conventional methods, then analysis complexity is reduced, but measurement precision and manufacturing precision deteriorate
Solution Approach 1:
The patent segments the heterogeneous sulfated polysaccharide population into distinct structural categories based on degree of sulfation, molecular weight ranges, and sequence patterns. This segmentation allows complex heterogeneous structures to be analyzed through multiple simplified dimensional parameters, resolving the contradiction between analysis complexity and measurement precision
Solution Approach 2:
The patent introduces multiple new parameters for characterization including degree of sulfation, molecular weight distribution profiles, and specific sequence signatures. By changing from conventional single-parameter analysis to multi-parameter characterization, the patent achieves higher measurement precision while maintaining manageable analysis complexity through systematic parameter organization
2Ease of operation
If conventional analysis methods are used for LMWH products, then ease of operation is maintained, but reliability and manufacturing precision deteriorate due to batch-to-batch variability
Solution Approach 1:
The patent establishes feedback mechanisms where structural signature data from each batch is compared against reference standards and previous batches. This feedback loop enables identification of deviations from desired specifications, allowing for real-time quality control and ensuring batch-to-batch consistency while maintaining ease of operation through automated comparison algorithms
Solution Approach 2:
The patent implements multiple quality parameters including degree of sulfation ranges, molecular weight distribution profiles, and sequence signature patterns that must be satisfied for batch acceptance. These additional parameters provide more comprehensive quality assurance, improving reliability without significantly complicating the analysis process
3Manufacturing precision
If structural characterization of heterogeneous polysaccharides is performed using detailed methods, then manufacturing precision and product standardization improve, but difficulty of detecting and measuring increases
Solution Approach 1:
The patent divides the structural characterization into separate detectable components: degree of sulfation measured by one method, molecular weight distribution by another, and sequence patterns by a third. This segmentation of measurement tasks reduces the difficulty of detecting and measuring each individual parameter while collectively achieving comprehensive structural characterization and product standardization
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the creation of standardized LMWH preparations with enhanced activity and bioavailability, reducing side effects and increasing their therapeutic utility across a broader patient population while ensuring batch consistency.
Implementation Method 1
analyzing techniques such as MALDI-MS, ESI-MS, and HPLC
Implementation Method 2
analyzing techniques such as MALDI-MS, ESI-MS, and HPLC
Implementation Method 3
analyzing techniques such as MALDI-MS, ESI-MS, and HPLC
Data Source
AI summary
The invention relates to methods and products associated with analyzing and monitoring heterogeneous populations of sulfated polysaccharides. In particular therapeutic heparin products including low molecular weight heparin products and methods of analyzing and monitoring these products are described.